Functional evaluation of the human pancreas before and in the early period after hyperfractionated accelerated radiochemotherapy.
Horst
Eckehard
E
Department of Radiation Oncology, University of Münster, Germany. horste@uni-muenster.de
Seidel
Matthias
M
Micke
Oliver
O
Rübe
Christian
C
Schäfer
Ulrich
U
Willich
Normann
N
D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D002096:C-Peptide / Q000378:metabolism; D003131:Combined Modality Therapy; D019583:Dose Fractionation, Radiation; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D005947:Glucose / Q000378:metabolism; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007328:Insulin / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010179:Pancreas / Q000378:metabolism / Q000503:physiopathology*; D010196:Pancreatic Elastase / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000503:physiopathology / Q000532:radiotherapy*
D000964:Antimetabolites, Antineoplastic; D002096:C-Peptide; D006454:Hemoglobins; D007328:Insulin; D010196:Pancreatic Elastase; D005947:Glucose; D005472:Fluorouracil